By Digifin Pty Ltd · About this coverage
Key Points
- Board will not recommend TDA's $11.80 per share indicative offer
- Board intends to engage with TDA on a proposal it could recommend
- No certainty of a binding offer or transaction
About Challenger (ASX:CGF)
Challenger Limited is an ASX-listed retirement income and investment management group headquartered in Sydney. It sells fixed term, lifetime and index-linked income products to Australian retirees through its life insurance subsidiary, Challenger Life Company, and reinsures annuity business for overseas partners. It also runs a funds management business for institutional and retail clients, and invests the assets backing its annuity liabilities across fixed income, credit and property.
Challenger (ASX:CGF)'s Board has rejected the current price offered by its largest shareholder but will keep talking, after considering the indicative offer it disclosed on 19 October 2026.
TAL Daiichi Life Australia Pty Limited (TDA) made a non-binding and conditional indicative offer to acquire the remaining ordinary shares in Challenger it does not already own, by way of a scheme of arrangement, at a price of $11.80 per share. The Board has concluded the offer is not at a level it could recommend to shareholders. Challenger describes TDA as its largest shareholder and a commercial partner, and the Board intends to engage with TDA to see whether a proposal can be reached that it could recommend.
The release does not state what price the Board would support, the size of TDA's existing holding or whether TDA intends to revise its offer. There is no certainty of a binding offer or that any transaction will eventuate.
Source: Challenger Limited (ASX:CGF), 26 October 2026. Summary content supplied by Digifin Pty Ltd.
News summary only, not financial advice. It does not consider your objectives, financial situation or needs.